Indianapolis? Eli Lilly and Co. said Wednesday it has agreed to plead guilty to a federal misdemeanor and pay $36 million to settle charges that it illegally marketed and promoted its Evista ...
Walter Tom Smith was on the brink of making his dream a reality. It was just days before he was set to open Walter's Family Restaurant in downtown Edinburgh when he disappeared on Sept. 3, 2006. His ...
Eli Lilly and Co. said in October it will invest ... The new funding will bring the Indianapolis-based drugmaker’s total investment in the Lebanon site to $13.5 billion, making the development ...
Tech entrepreneur and Tesla (TSLA, Financials) CEO Elon Musk's disclosure of using weight-loss pharmaceuticalsincluding Eli Lilly's (LLY, Financials) Mounjaro and Novo Nordisk's Ozempichas drawn ...
Eli Lilly and Co. CEO David Ricks—IBJ’s newsmaker ... The new funding will bring the Indianapolis-based drugmaker’s total investment in the Boone County site to more than $13 billion ...
Adam Spatacco has positions in Eli Lilly and Novo Nordisk. The Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends Johnson & Johnson, Moderna, and Novo Nordisk.
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...
Shelby Knowles / Bloomberg via Getty Images Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat moderate-to-severe obstructive ...
Eli Lilly announced FDA approval of Zepbound as the first prescription medicine for adults with moderate-to-severe obstructive sleep apnea. In addition, adults on Zepbound lost an average of 45 ...
Eli Lilly (LLY) stated: “In a win for patients, the judge overseeing Lilly’s International Trade Commission case determined that U.S. Customs and Border Protection should prevent the illicit ...